Author
Dept. of Animal Medicine, Fac. Vet. Med. Assiut University
Abstract
Keywords
Dept. of Animal Medicine,
Fac. Vet. Med.AssiutUniversity.
DIAGNOSI S OF BOVINE LEUKOSIS IN IMPORTED DAIRY CATTLE IN KINGDOM OF SAUDI ARABIA USING THREE DIFFERENT TECHNIQUES
(With 4 Tables and 2 Figures)
By
(Received at 2/3/2008)
تشخيص مرض الليکوزس البقرى فى أبقار إنتاج الحليب المستوردة فى المملکة العربية السعودية بإستخدام ثلاث تقنيات مختلفة
فى هذه الدراسة تم فحص عدد 300 بقرة إنتاج حليب مستوردة من استراليا لتشخيص مرض الليکوزس البقرى من خلال التعرف على الأجسام المضادة والحامض النووى وأنتيجين فيروس اللوکيميا البقرى المسبب لهذا المرض وذلک بإجراء اختبار الإليزا (على عينات فردية من السيرم) والتفاعل التبلمرى المتسلسل (على عينات من الدم) وتقنية الصبغة المناعية النسيجية (على عينات من الغدة اللمفاوية فوق الضرع). مئتان من هذه الحيوانات تم فحصها بعد وصولها مباشرة إلى محجر ميناء جدة الإسلامى بالمملکة العربية السعودية أثناء فترة الحجر الإجباري (21يوم) وذلک بعمل الاختبارات السابق ذکرها مرة واحدة فقط. أما المائة بقرة المتبقية فقد تم اختيارها من مزرعة إنتاج حليب قامت باستيراد هذه الأبقار من استراليا أيضا قبل عام من بداية هذه الدراسة وتم فحصها بإجراء الاختبارات الثلاثة ثلاث مرات متتالية بفاصل زمنى شهر بين کل مرة و أخرى بالإضافة إلى فحص عينة حليب مختلطة تمثل کل المزرعة باستخدام اختبار الإليزا. خمسون من هذه المائة تم اختيارهم عشوائيا وخمسون تم اختيارهم من الأبقار ذات إنتاج الحليب المنخفض فى المزرعة. بالنسبة للأبقار حديثة الاستيراد الموجودة فى محجر الميناء , تم التعرف عل الأجسام المضادة لفيروس اللوکيميا فى عدد 16 بقرة والحامض النووى لفيروس اللوکيميا فى عدد21 بقرة و أنتيجين فيروس اللوکيميا فى عدد 24 بقرة بعد إجراء اختبار الإليزا والتفاعل التبلمرى المتسلسل والصبغة المناعية النسيجية على التوالى. بعد عمل الفحص الأول لأبقار المزرعة تم التعرف على الأجسام المضادة لفيروس اللوکيميا فى عدد 6 بقرات (خمسة منها من الأبقار ذات إنتاج الحليب المنخفض) والحامض النووى لفيروس اللوکيميا فى عدد 7 بقرات (ستة منها من الأبقار ذات إنتاج الحليب المنخفض) وأنتيجين فيروس اللوکيميا فى عدد 9 بقرات (ثمانية منها من الأبقار ذات إنتاج الحليب المنخفض). فى الفحص الثانى لأبقار المزرعة لم تتغير نتيجة اختبار الإليزا بينما زاد عدد الحالات الإيجابية إلى 9 , 11 مع التفاعل التبلمرى المتسلسل والصبغة المناعية النسيجية على التوالى. الفحص الثالث لأبقار المزرعة أظهر التحول السيرولوجى الذى حدث فى بقرتين أعطتا نتائج سلبية مع اختبار الإليزا الأول والثانى بينما نتائج التفاعل التبلمرى المتسلسل والصبغة المناعية النسيجية لم تتغيرا عن الفحص الثانى. عينة الحليب المشترکة الممثلة لکل المزرعة کانت إيجابية للأجسام المضادة للفيروس بعد إجراء اختبار الإليزا عليها فى الثلاث فحوصات . نتائج هذا العمل أوضحت أن عدد غير قليل من أبقار إنتاج الحليب المستوردة من استراليا مصاب بمرض الليکوزس البقرى الذى ظهر من الدراسة أنه يؤثر على انتاج الحليب مما يؤکد على أهمية استخدام التشخيص المعملى لفحص أبقار إنتاج الحليب المستوردة قبل السماح بدخولها حيث کانت کل الحيوانات المصابة سليمة ظاهريا. أثبتت هذه الدراسة أن تقنية الصبغة المناعية النسيجية أشد حساسية من التفاعل التبلمرى المتسلسل واختبار الإليزا کما أن التفاعل التبلمرى المتسلسل أشد حساسية من اختبار الإليزا بالإضافة إلى أن تقنية المناعة النسيجية والتفاعل التبلمرى المتسلسل أمکنهما التعرف على الحالات الإيجابية الجديدة للإصابة بالفيروس قبل أن يتمکن اختبار الإليزا من ذلک. من کل النتائج التى تم تسجيلها فى هذه الدراسة يمکن التوصية بضرورة استخدام التفاعل التبلمرى المتسلسل مع اختبار الإليزا فى فحص جميع أبقار إنتاج الحليب المستوردة لتشخيص مرض الليکوزس البقرى وعدم السماح بدخول أى حيوان مصاب إلى داخل المملکة حيث لم يتم تسجيل هذا المرض رسميا بالمملکة حتى الآن بالرغم من أن العمل الحالى أثبت وجود هذا المرض فى أحد مزارع انتاج الحليب. للسيطرة على هذا المرض يجب فحص جميع مزارع انتاج الحليب خاصة تلک التى تعانى من نقص إنتاج الحليب دون وجود سبب واضح وذلک بعمل اختبار الإليزا على عينة حليب مختلطة تمثل کل المزرعة وفى حالة ايجابية هذه العينة يجب فحص جميع حيوانات المزرعة باستخدام اختبار الإليزا والتفاعل التبلمرى المتسلسل معا والتخلص من الحيوانات الإيجابية لهذا المرض. بالرغم من شدة حساسية تقنيةالصبغة المناعية النسيجية إلا أننى لا أوصى باستعمالها فى الوقت الحالى نظرا لتعقد خطواتها وتکلفتها العالية لکن مع استمرار العمل على تبسيط خطوات هذه التقنية وتقليل التکلفة قد تکون هى التقنية المثلى لتشخيص هذا المرض فى المستقبل.
In 1871, the observation of yellowish nodules in the enlarged spleen of a cow was considered to be the first reported case of bovine leukemia (enzootic bovine leukosis). The etiological agent of this worldwide lymphoproliferative disease is bovine leukemia virus (BLV), also termed bovine leukosis virus, that primarily affects lymphoid tissues of animals. BLV belongs to the delta retrovirus genus which also includes the related human T-lymphotropic virus type 1 (HTLV-1) (Beier et al., 1998; Ott et al., 2003; Gillet et al., 2007; Kohara and yokomizo, 2007). The disease causes great economic losses allover the world (Fulton et al., 2006; Tiwari et al., 2007) and usually infect dairy cattle. Usui et al., (2003) in their study recorded 3.3% BLV-seropositive cattle in dairy farm while all examined beef cattle were seronegative for BLV. This disease infects cattle, sheep and water buffaloes (Meas et al., 2000; Willems et al., 2000). The disease transmitted through colostrums, milk (Meas et al., 2002) and rectal palpation (Kohara et al., 2006) while transmission through semen of infected bulls hadn’t proven yet (Choi et al., 2002; Meas et al., 2002).
BLV induces a chronic infection in cattle, which develop in three possible pathological forms: asymptomatic course, persistent lymphocytosis (PL) and lymphosarcoma (Trono et al., 2001; Debacq et al., 2003). Infected cattle were classified into lymphocytotic and nonlymphocytotic groups. Nonlymphocytotic cattle comprised 2 subgroups: a group with high proviral load and strong immune response, and a group with low proviral load and weaker immune response. Nonlymphocytotic cattle with high or low proviral load could be efficient transmitters (as efficient as lymphocytotic cattle), but most cattle with low proviral load do not develop anti-BLV antibodies so, it couldn`t be detected serologically (Gutierrez et al., 2001; Juliarena et al., 2007). Viral spread by mitotic cell division accounts for most of the proviral loads during the asymptomatic phase has occurred (Florins et al., 2007).
Once infected, cattle remain virus carriers for life and start to show a serological reaction within a few weeks after infection. Eradication and control of the disease is based on early diagnostic and segregation of the carriers (Suh et al., 2005). The agar gel immunodiffusion (AGID) test has been the serological test of choice for routine diagnosis of serum samples for several years. BLV constitutes a serious sanitary problem for dairy producers in many countries. This problem increased by lack of rapid accurate diagnosis as most laboratories still depend on the official AGID which proved to has poor sensitivity as routine test for diagnosis of BLV Nevertheless, in more recent years, the enzyme-linked immunosorbent assay (ELISA) has replaced the AGID for large scale testing (Trono et al., 2001).
The ELISA using either milk or serum to detect BLV-infected animals had comparable sensitivity and specificity with the official AGID and considered the most widely accepted test for the serological diagnosis of BLV infection. Therefore, ELISA can be used as an alternative test in monitoring and control programs of BLV (Monti et al., 2005a; VanLeeuwen et al., 2005; VanLeeuwen et al., 2006). and is advisable as a method of choice for screening investigation (Kurdi et al., 1999).
The practical application of polymerase chain reaction (PCR) for the diagnosis of bovine leukemia virus (BLV) infections in naturally infected cattle was evaluated and compared to serological tests, the PCR was definitely found to be a more sensitive method, yielding the highest number of positive results (10% more compared t0 ELISA, and 17.7% more compared to AGID) (Fechner et al., 1996). Many authors have recorded the sensitivity of PCR in comparison with other diagnostic tests of BLV (Nagy et al., 2003; Kohara et al., 2006)
BLV-infected cattle with low, transient or without BLV-antibody titers are difficult to identify as BLV-infected. These animals may be sources for new infections. Therefore, Monti et al., (2005a) concluded that there is currently no reference test capable of serving as a gold standard technique for diagnosis of BLV. Although KSA imported large number of dairy cattle and has many large dairy farms allover the country, no studies have been conducted yet to determine the suitable and sensitive test for diagnosis of BLV infection. Also, there is no routine examination of imported dairy cattle for BLV before permission of introducing of these animals into KSA. So, it was the aim of the study to compare the suitability and sensitivity of enzyme-linked immunosorbent assay (ELISA) as serological test, polymerase chain reaction (PCR) as molecular biology-based assay and avidine biotin complex (ABC) immunoperoxidase as immunohistochemical technique to reach to a standard technique for diagnosis of BLV. Detection and elimination of infected cattle for control of this infection was another important aim of the study.
Animals:
300 dairy cattle imported from Australia were used in this study, out of them 200 were immediately imported and arrived to Jeddah airport. The remaining 100 cattle were imported and were added to dairy farm about one year before beginning of this work. All these cattle were apparently healthy.
serum:
5 ml blood was collected from each examined cattle to obtain serum for ELISA.
Blood:
5 ml blood was collected from each examined cattle to obtain viral nucleic acid (if present) for PCR.
Milk:
One milk sample taken from bulk milk tank in the dairy farm was obtained for performing ELISA.
Lymph node biopsy:
Lymph node biopsies from supra mammary lymph node were obtained using biopsy core needle (Stiefel Laboratories, Winterthur, Switzerland), Washburn et al., (2007). These biopsies were used for detection of BL viral antigen by immunohistochemical staining using ABC method.
ELISA (in serum):
1- Serum samples were diluted twenty-five fold (1:25) with sample diluent (20µl serum + 480µl diluent).
2- Bovine Leukemia Virus (BLV) and Normal Host Cell (NHC) antigen coated plates and samples position were recorded (Table 1).
Table 1: Layout of the used ELISA plates.
|
BLV |
NHC |
BLV |
NHC |
BLV |
NHC |
BLV |
NHC |
BLV |
NHC |
BLV |
NHC |
A |
N |
N |
5 |
5 |
13 |
13 |
21 |
21 |
29 |
29 |
37 |
37 |
B |
N |
N |
6 |
6 |
14 |
14 |
22 |
22 |
30 |
30 |
38 |
38 |
C |
P |
P |
7 |
7 |
15 |
15 |
23 |
23 |
31 |
31 |
39 |
39 |
D |
P |
P |
8 |
8 |
16 |
16 |
24 |
24 |
32 |
32 |
40 |
40 |
E |
1 |
1 |
9 |
9 |
17 |
17 |
25 |
25 |
33 |
33 |
41 |
41 |
F |
2 |
2 |
10 |
10 |
18 |
18 |
26 |
26 |
34 |
34 |
42 |
42 |
G |
3 |
3 |
11 |
11 |
19 |
19 |
27 |
27 |
35 |
35 |
43 |
43 |
H |
4 |
4 |
12 |
12 |
20 |
20 |
28 |
28 |
36 |
36 |
44 |
44 |
N=negative control P=positive control BLV=bovine leukemia virus NHC=normal host cell 1-44=samples
3- 200µl of negative control was dispensed into BLV wells A1 and B1 and into NHC wells A2 and B2.
4- 200µl of positive control was dispensed into BLV wells C1 and D1 and into NHC wells C2 and D2.
5- 200µl of diluted serum sample dispensed into the remaining wells.
6- Incubation for 90 minutes at room temperature (20ºC-25ºC).
7- Liquid contents of all wells were aspirated and plate washed 4 times with 300µl/well wash solution using automated washer, Well wash4 (Labsystems, A thermo Bioanalysis Company, Research technology Devision, Helsinki, FINLAND ).
8- 100µl of Anti-Bovine IgG: HRPO (Horseradish Peroxidase) conjugate was added to each well.
9- Incubation for 30 minutes at room temperature (20ºC-25ºC).
10- Repeat step 7.
11- 100µl of TMB (Tetramethylbenzidine) substrate was dispensed into each well.
12- Incubation for 15 minutes at room mtemperature (20ºC-25ºC).
13- 100µl stop solution was dispensed into each well.
14- Spectrophotometer (Labsystems, A Thermo Bioanalysis Company, Research technology Devision, Helsinki, FINLAND) was blanked with air.
15- Optical density (OD) of samples and controls were measured at A650 wave length.
16- Calculation of results
a- For the assay to be valid, the negative control mean (NCX) for the BLV wells and the NHC wells must be less than or equal to 0.200 and the difference {positive control mean (PCX) – NCX} for the BLV wells must be greater than or equal to 0.075.
b- Calculation of NCX
NCX = A1 + B1
2
c- Calculation of PCX
PCX = C1 + D1
2
d- Calculation of sample to positive (S/P) ratio
S/P = OD of sample - NCX
e- Calculation of sample to normal host cell (S/NHC) ratio
S/NHC = OD of sample with BLV
17- Interpretation of the results: Are shown in Tble 2.
Table 2: Interpretation of ELISA results.
|
NEGATIVE |
POSITIVE |
S/P RATIO |
Less than 0.500 |
Greater than or equal to o.500 |
S/NHC RATIO |
Less than 1.80 |
Greater than or equal to 1.80 |
ELISA (in bulk milk sample):
Preparation of sample:
Whole milk sample were centrifuged for 15 minutes at 2000xg. Skim milk from underneath the fat layer was used as a milk sample.
Test protocol:
The same protocol as mentioned in serum except that negative,positive control and milk sample were added in a volume of 300µl, the first incubation of ELISA plate must be at 4ºC for 12-18 hours.
ELISA was performed according to manufacturer’s (IDEXX, Idexx laboratories inc, Westbrook, Maine04092 ,USA) directions.
a-Nucleic acid extraction
Viral nucleic acid was isolated by a modified method of the procedure described by Chomczynski and Sacchi (1987). Briefly, 5µl purified leukocytes from examined animal was mixed with an equal volume of guanidine isothiocyanate lysis buffer (8M guanidine isothiocyanate, 50mM sodium citrate, 100 mM 2-mercaptoethanol, 1% sarkosyl). The solution was sequentially mixed with the following: 1µl sodium acetate (pH4), 10µl phenol (pH4.3), 2µl chloroform. The mixture was centrifuged at 16.000 g for 15 min, and the aquas phase was obtained and combined with equal volume of isopropanol to precipitate the nucleic acid. After centrifugation the resulting pellet was washed with 75% ethanol, dissolved in water and kept at –86ºC till use.
b-Primer design
Primers were selected according to genetic map of BLV (Oblap et al., 1997; Reichert and Stec 1999; Monti et al., 2005b; Felmer et al., 2005; Hemmatzadeh 2007). Sequences and specifications of the used primers are shown in Table 3.
Table 3: Sequences and specifications of the used primers
PRIMER |
SEQUENCE 5`-3` |
POAITION |
EXPECETD VIRUS |
1 |
TCT AGC TCA GCT CAG TAG CCA |
2948 – 2968 |
BLV (Brazilian subspecies) |
2 |
CTA CCT TGC AGA TCT CAT C |
2984 – 3002 |
BLV (Australian subspecies) |
3 |
GCT TGT CGA AGC TCT GCA ATG C |
3164-3185 |
BLV (Japanese subspecies) |
c-PCR amplification of viral nucleic acid
Primers and viral nucleic acid were incubated at 75ºC for 10minutes and quickly cooled on ice for 10 min to allow annealing of the primer to nucleic acid. Then added to PCR reaction mixture which contained 1X PCR buffer (500mM Kcl; 100mM Tris-Hcl,pH8.3; 15mM Mg Cl2), 0.25mM dithiothreitol, 1mM of each deoxynucleotide (dATP, dCTP, dGTP, dTTP) and 2.5 unit of amplitaq (Perkin-Elmer Cetus Corp., Norwalk,CT) in a reaction volume of 100µl. The PCR reaction was 30 cycles with the following reaction parameters: template denaturation at 94ºC for 1min, primer annealing at 55ºC for 1min and extension at 72ºC for Imin. A single final extension step was done at 72ºC for 10 min to complete the amplification reaction.
d-Analysis of PCR products
Amplified PCR products were analyzed by electrophoresis on 1.5% agarose gel (Sambrook et al., 1989) and the specific nucleic acid band was identified {positive results were detected by presence and location of white band (Fig. 1)}.
PCR was performed according to method described by Reichert and Stec, (1999).
ABC:
Lymph node biopsies were examined for detection of BLV viral antigen using Avidin Biotin Complex (ABC) immunoperoxidase method as described by Hsu et al., (1981) and Ikeda et al., (2005) as follow:-
1-Paraffin sections from examined lymph node were cut at 6µm and picked up from warm water (40ºC) to Poly-L-Lysine coated slide and dry overnight in an oven at 37ºC.
2-Sections were deparaffinized and rehydrated by sequential immersion of the slides in xylene followed by graded concentrations of ethanol and then tap water.
3-The sections were treated for proteolysis with phosphate buffered saline (PBS, pH 7.6 prewarmed to 37ºC) containing 0.25% trypsin (Fluka, Buchs, Switzerland) and 0.02% CaCl2 for 60 min at 37ºC.
4-After proteolytic treatment, the sections were washed three times each for 5 min in Tris-PBS (pH 7.6).
5-Endogenous peroxidase activity was blocked by immersion of slides in solution of 0.05%H2O2 in methanol for 30 min at room temperature (RT).
6-Before incubation with primary specific monoclonal antibodies (Tibueg, Netherlands) against BLV (gp 51), the sections were overlaid with normal rabbit serum diluted 1:10 in PBS for 20 min at RT.
7-The monoclonal mouse antibodies against BLV were applied diluted 1:100. Primary antibodies were incubated with the sections for 18 hours in humid chamber at 4ºC.
8-The slides were washed three times in Tris-PBS for 5 min each.
9-The biotinylated secondary rabbit anti-mouse-immunoglobulin (Amersham, Little Chalfont, Buckinghamshir, UK) diluted 1:200 in PBS were applied for 30 min at RT.
10-After washing in Tris-PBS three times for 5 min, the sections were incubated with ABC complex which prepared according to manufacturer’s direction (Vectostain Elite ABC Vector Laboratories, Burlingam, CA, USA) for 30 min at RT.
11-Antigen binding was demonstrated with a solution of 0.05% 3,3-diaminobenzidine tetrahydrochloride (DAB, Fluka) in Tris-PBS containing 0.01% H2O2 (prepared immediately before use) as peroxidase substrate for 5 min at RT.
12-All sectrions were counterstained with Mayer’s hematoxylene, dehydrated with a series of alcohol, cleared with xylene and a cover slide was applied with Entellan (Merck, Darmstadt, Germany).
13-The specificity of the immunohistochemical reactions was checked by replacing the primary antisera with non-immune sera or by omitting the secondary antibodies or the ABC solution. Positive results were detected by presence of brown staining of viral antigen (Fig.2).
(I) Imported cattle in quarantine
1-ELISA
16 cattle were positive and 184 were negative to BLV-antibodies.
2-PCR
21 cattle were positive and 179 were negative to BL viral nucleic acid.
The positive cattle were belong 3 subgroups, Australian (16 cattle), Japanese (4 cattle) and Brazilian (one cattle).
3-ABC
24 cattle were positive and 176 were negative to BLV antigen.
(II) Imported cattle in dairy farm
1-ELISA
a-ELISA (serum samples)
a- First: 6 cattle (5 of them from low milk producer cattle) were positive and 94 were negative to BLV-antibodies.
b- Second: No change from the result of the 1st examination
c- Third: 8 cattle (7 of them from low milk producer cattle) were positive and 92 were negative to BLV-antibodies.
b-ELISA (pooled bulk tank milk sample)
The pooled bulk tank milk sample which represent the whole farm was positive to 3 successive examinations.
2-PCR
a- First: 7 cattle (6 of them were from low milk producer cattle) were positive and 93 were negative to BL viral nucleic acid.
b- Second: 8 cattle (7 of them were from low milk producer cattle) were positive and 92 were negative to BL viral nucleic acid.
c- Third: No change from the result of 2nd examination
d- Positive animals were belong 3 subgroups, Australian (4 cattle), Japanese (2 cattle) and Brazilian (one cattle).
3-ABC
a- First: 9 cattle (8 of them were from low milk producer cattle) were positive and 91 cattle were negative to BL viral antigen.
b- Second: 11 cattle (10 of them were from low milk producer cattle) were positive and 89 cattle were negative to BL viral antigen.
c- Third: No change from the result of 2nd examination.
Results of laboratory investigation are summarized in Table (4), results of PCR are shown in fig.1and results of ABC are shown in Fig.2
Table 4: Results of laboratory investigation.
|
ELISA 1st 2nd 3rd + - + - + - |
PCR 1st 2nd 3rd + - + - + - |
ABC 1st 2nd 3rd + - + - + - |
Cattle in quarantine |
16 184 No No |
21 179 No No |
24 176 No No |
Cattle in a farm a-low milk producer cattle b-Randomly selscted cattle |
5 45 5 45 7 43
1 49 1 49 1 49 |
6 44 8 42 7 43
1 49 1 49 1 49 |
8 42 10 40 10 40
1 49 1 49 1 49 |
No=not performed
Fig. 1: Results of PCR
Lane1 (DNA size marker).Lane2 (BLV,Australian subspecies).Lane3 (BLV, Japanese subspecies).Lane4 (BLV, Brazilian subspecies).Lanes 5-8 (negative results).
Fig. 2:Immunohistochemical assay using ABC technique in supra mammary lymph node. Brown staining represent BL viral antigen.
Results of this study proved that PCR more sensitive than ELISA where PCR detected BLV viral nucleic Acid in 30 cattle while ELISA detected Antibodies against BLV in 24 cattle only. PCR is a highly sensitive method and might be successfully used and economically advantageous for different practical applications in detection of BLV infection in naturally infected cattle. PCR-technique compared to the serological tests proved to be much more sensitive (Fechner et al., 1996; Beier et al., 1998; Kurdi et al., 1999; Konnai et al., 2003; Nagy et al., 2003; Kohara et al., 2006). This difference in sensitivity between ELISA and PCR may be explained by the conclusion of Gutierrez et al., (2001) and the results of Juliarena et al., (2007) who proved that most cattle with low proviral load do not develop anti-BLV antibodies and observed that all cattle that had positive results for the PCR had BLV antibodies, but cattle with consistantly low antibody titers required examination of sequential DNA samples to detect viral sequences
However, 2 cattle were ELISA positive and PCR negative, 8 cattle were PCR positive and ELISA negative. At the same time, 11 negative cattle with ELISA and 5 negative cattle with PCR were positive with ABC method. These results proved that ABC is more sensitive than PCR and ELISA and also showed that PCR or ELISA alone is not sufficient for accurate diagnosis of BVL. Klintevall et al., (1994) in their experimental study observed some infected animals without detectable levels of BLV proviral DNA in blood and without circulating antibodies. Of 18 cattle imported from the Slovak Republic and kept in a quarantine stable, four were found to be BLV provirus positive by PCR, while serological tests indicated one animal positive and three negative. Therefore, it is impossible to prevent the spread of the infection from one country to another by serological testing only (Fechner et al., 1996; Trono et al., 2001). The findings of persistently seronegative PCR positive and seropositive PCR negative cattle indicate that further work is needed to overcome the problem of diagnosis of BLV. Present serological screening methods may not have sufficient sensitivity for determining BLV status in some circumstances. PCR assay alone is unreliable for routine detection of BLV in herds with high prevalence of the disease (Jacobs et al., 1992; Nagy et al., 2003). Schell et al., (2004) observed leucotic and tumorous alterations which accompanied to BLV infection while blood serum was negative for antibodies directed against BLV. Beier et al., (1998) and Nagy et al., (2007) concluded that PCR is more sensitive than ELISA, therefore it is considered a useful tool to exclude or confirm BLV-infection in cattle with doubtful serological results and may be used to complement the serological tests in the diagnosis of BLV-infection.
PCR used in this work could detect and differentiate between three subspecies of BLV (Fig. 1) while ELISA couldn’t differentiate between them, Australian subspecies was the most common among infected cattle. Different BLV provirus variants had been recorded in the examined animals. Kurdi et al., (1999) recorded 3 subgroups of BLV. Belgian, Japanese and Australian subspecie of BLV were reported by Limanskii et al., (2004) who observed Australian subspecies in 92% of infected cattle. Camargos et al., (2007) concluded that BLV belonged to at least two phylogenetic clusters. Four different genetic groups of BLV were identified by phylogenetic analysis (Camargos et al., 2002; Felmer et al., 2005). These subgroups were identified by PCR (Monti et al., 2005b; Hemmatzadeh, 2007). A serologic subgroup of bovine leukemia virus (BLV) has not been identified, whereas genetic diversity among BLVs has been reported by PCR (Beier et al., 2001; Licursi et al., 2003). Presence of the same subspecies of BLV in both animals in quarantine and farm animals (which imported from Australia and examined in this study) proved that these imported cattle harbor BLV before their arrival to KSA. Beier et al., (1998) after their study concluded that cattle in the same area usually infected with the same BLV provirus variant.
In dairy farm examined in this study, most BLV-positive cattle were low milk producer. Ott et al., (2003) recorded decrease in milk produced by dairy cattle infected with BLV.
In the present investigation, detection of antibodies against BLV in bulk tank milk sample by ELISA proved to be a good method for primary diagnosis of BLV in dairy farms. Examination of pooled milk samples with the ELISA provides a reliable, practical, and economic procedure for identification of BLV-infected herds (Gutierrez et al., 2001).
REFERENCES
Beier, D.; Blankenstein, P. and Fechner, H. (1998): Possibilities and limitations for use of the polymerase chain reaction (PCR) in the diagnosis of bovine leukemia virus (BLV) infection in cattle. Dtsch.Tierarztl Wochenschr., 105 (11): 408-412.
Beier, D.; Blankenstein, P.; Marquardt, O. and Kuzmak, J. (2001): Identification of different BLV provirus isolates by PCR, RFLPA and DNA sequencing. Berl Munch Tierarztl Wochenschr. 114(7-8): 252-256.
Camargos, M.; Stancek, D.; Rocha, M.; Lessa, L.; Reis, J. and Leite, R. (2002): Partial sequencing of env gene of bovine leukaemia virus from Brazilian samples and phylogenetic analysis. J. Vet. Med. B Infect Dis Vet. Public Health. 49(7): 325-331.
Camargos, M.; Pereda, A.; Stancek, D.; Rocha, M.; dos Reis, J.; Greiser-Wilke, I. and Leite, R. (2007): Molecular characterization of the env gene from Brazilian field isolates of Bovine leukemia virus.: Virus Genes.; 34(3) : 343-50.
Chomczynski, P. and Sacchi, N. (1987): Single-step method of RNA isolation by acid guandinium thiocyanate-phenol-chloroform extraction.Ann.Biochem., 162: 156-159.
Choi, K.; Monke, D. and Stott, J. (2002): Absence of bovine leukosis virus in semen of seropositive bulls. J. Vet. Diagn. Invest., 14(5) : 403-406.
Debacq, C.; Asquith, B.; Reichert, M.; Burny, A.; Kettmann, R. and Willems, L. (2003): Reduced Cell Turnover in Bovine Leukemia Virus-Infected, Persistently Lymphocytotic Cattle. J. Virol., 77 (24): 13073-13083.
Fechner, H.; Kurg, A.; Geue, L.; Blankenstein, P.; Mewes, G.; Ebner, D. and Beier, D. (1996): Evaluation of polymerase chain reaction (PCR) application in diagnosis of bovine leukaemia virus (BLV) infection in naturally infected cattle. Zentralbl Veterinarmed, B. 43(10): 621-630
Felmer, R.; Muñoz, G.; Zúñiga, J.; and Recabal, M. (2005): Molecular analysis of a 444 bp fragment of the bovine leukaemia virus gp51 env gene reveals a high frequency of non-silent point mutations and suggests the presence of two subgroups of BLV in Chile. Vet Microbiol. 108(1-2): 39-47.
Florins, A.; Gillet, N.; Boxus, M; Kerkhofs, P; Kettmann,R and Willems,L(2007): Even attenuated Bovine Leukemia Virus Proviruses can be pathogenic in sheep. J. Virol., 81 (18):10195-10200.
Fulton, B.; Portella,M.; and Radke, K.(2006): Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node. J Virol. 80(16): 7873-7884.
Gillet, N.; Florins, A.; Boxus, M.; Burteau, C.; Nigro, A.; Vandermeers, F.; Balon, H.; Bouzar, A.B.; Defoiche, J.; Burny, A.; Reichert, M.; Kettmann, R. and Willems L. (2007): Mechanisms of leukehemogenesis induced by bovine leukemia virus:prospects for novel anti-retroviral therapies in human. Retrovirology., (16): 14-18.
Gutiérrez, S.E..; Dolcini, G.L.; Arroyo, G.H..; Rodriguez Dubra, C.; Ferrer, J.F. and Esteban, E.N. (2001): Development and evaluation of a highly sensitive and specific blocking enzyme-linked immunosorbent assay and polymerase chain reaction assay for diagnosis of bovine leukemia virus infection in cattle. Am. J. Vet. Res., 62 (10): 1571-1577.
Hemmatzadeh, F. (2007): Sequencing and phylogenetic analysis of gp51 gene of bovine leukaemia virus in Iranian isolates.: Vet. Res. Commun. 31(6): 783-789.
Hsu, S.; Raine, Land Fanger, H. (1981): The use of avidine-biotin peroxidase complex in immunoperoxidase technique. Am. J. Clin. Pathol., 75: 816-821.
Ikeda, M.; Konnai, S.; Onuma, M.; Ishiguro, N.; Goryo, M. and Okada, K. (2005): Immunohistochemical analysis of expression patterns of tumor necrosis factor receptors on lymphoma cells in enzootic bovine leucosis. : J. Vet. Med. Sci., 67(4): 425-32.
Jacobs, R.; Song, Z.; Poon, H.; Heeney, J.; Taylor, J.; Jefferson, B.; Vernau, W. and Valli, V. (1992): Proviral detection and serology in bovine leukemia virus-exposed normal cattle and cattle with lymphoma. Can. J. Vet. Res., 56(4): 339–348.
Juliarena, M.A.; Gutierrez, S.E. and Ceriani, C. (2007): Determination of proviral load in bovine leukemia virus-infected cattle with and without lymphocytosis. Am. J. Vet. Res., 68 (11): 1220-1225.
Klintevall, K.; Ballagi-Pordány, A.; Näslund, K. and Belák, S. (1994): Bovine leukaemia virus: rapid detection of proviral DNA by nested PCR in blood and organs of experimentally infected calves. Vet. Microbiol., 42 (2-3): 191-204.
Kohara, J. and Yokomizo, Y. (2007):In vitro and in vivo effects of recombinant bovine interferon-tau on bovine leukemia virus. J. Vet. Med. Sci., 69 (1): 15-19.
Kohara, J.; Konnai, S. and Onuma, M. (2006): Experimental transmission of Bovine leukemia virus in cattle via rectal palpation. Jpn. J. Vet. Res., 54 (1): 25-30.
Konnai, S.; Usui, T.; Ohashi, K. and Onuma, M. (2003): The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR. Vet. Microbiol. 94(4): 283 -294
Kurdi, A.; Blankenstein, P.; Marquardt, O. and Ebner, D. (1999): Serologic and virologic investigations on the presence of BLV infection in a dairy herd in Syria. Berl.Munch. Tierarztl Wochenschr., 112 (1): 18-23.
Licursi, M.; Inoshima, Y.; Wu, D.; Yokoyama, T.; González, E. and Sentsui, H. (2003): Provirus variants of bovine leukemia virus in naturally infected cattle from Argentina and Japan.: Vet. Microbiol. 96(1): 17-23.
Limanskiĭ, A.; Geue, L.; Limanskaia, O. and Beier, D. (2004): Typing of cattle leukemia virus circulating in the Ukraine. Vopr Virusol.; 49(1):39-44.
Meas, S.; Seto, J.; Sugimoto, C.; Bakhsh, M.; Riaz, M.; Sato, T.; Naeem, K.; Ohashi, K. and Onuma, M. (2000): Infection of bovine immunodeficiency virus and bovine leukemia virus in water buffalo and cattle populations in Pakistan. J. Vet. Med. Sci. 62(3): 329-331.
Meas, S.; Usui, T.; Ohashi, K.; Sugimoto, C. and Onuma, M. (2002): Vertical transmission of bovine leukemia virus and bovine immunodeficiency virus in dairy cattle herds. Vet. Microbiol., 84 (3): 275-282.
Monti, G.E.; Frankena, K.; Engel, B.; Buist, W.; Tarabla, H.D.; de Jong, M.C. (2005a): Evaluation of a new antibody-based enzyme-linked immunosorbent assay for the detection of bovine leukemia virus infection in dairy cattle. J.Vet.Diagn.Invest., 17 (5): 451-457.
Monti, G.; Schrijver, R. and Beier, D. (2005b): Genetic diversity and spread of Bovine leukaemia virus isolates in Argentine dairy cattle. Arch Virol., 150(3): 443-458.
Nagy, D.W.; Tyler, J.W.; Kleiboeker, S.B. and Stoker, A. (2003): Use of a polymerase chain reaction assay to detect bovine leukosis virus in dairy cattle. J. Am. Vet. Med. Assoc., 222(7): 983-985.
Nagy, D.W.; Tyler, J.W. and Kleiboeker, S.B. (2007): Timing of seroconversion and acquisition of positive polymerase chain reaction assay results in calves experimentally infected with bovine leukemia virus. Am. J. Vet. Res., 68 (1): 72-75.
Oblap, R.; Glazko, V. and Sozinov, A. (1997): The bovine leukosis virus and the diagnosis of infected animals. Tsitol.Genet., 31 (2): 41-43.
Ott, S.; Johnson, R. and Wells, S. (2003): Association between bovine-leukosis virus seroprevalence and herd-level productivity on US dairy farms. Prev. Vet. Med. 61(4):249-262.
Reichert, M. and Stec, J. (1999): Simultaneous use of two primer pairs increases the efficiency of polymerase chain reaction assay in the diagnosis of bovine leukemia virus infection. J. Vet. Diagn Invest. 11(6): 543-547.
Sambrook, J.; Fritsch, E. and Maniatis, T. (1989): Appendix E:Commonly used techniques in molecular cloning. In: C.Nolan (Ed) Molecular cloning. A laboratory Mannual. Cold spring harbor laboratory press, New York, P.73.
Schell, M.; Heckert, H. and Müller, K.E. (2004): Case report: lymphosarcoma in a cow.: Dtsch Tierarztl Wochenschr. 111(1): 38-41 .
Suh, G.H.; Lee, J.C.; Lee, C.Y.; Hur, T.Y.; Son, D.S.; Ahn, B.S.; Kim, N.C. and Lee, C.G. (2005): Establishment of a bovine leukemia virus-free dairy herd in Korea. J. Vet. Sci., 6 (3): 227-230
Tiwari, A.; Vanleeuwen J.A.; Dohoo, I.R.; Keefe, G.P.; Haddad, J.P.; Tremblay, R.; Scott, H.M. and Whiting T. (2007): Production effects of pathogens causing bovine leukosis, bovine viral diarrhea, paratuberculosis and neosporosis. J. Dairy Sci., 90 (2): 659-669.
Trono, K.G.; Pérez-Filgueira, D.M.; Duffy, S; Borca, M.V. and Carrillo, C. (2001): Seroprevalence of bovine leukemia virus in dairy cattle in Argentina: comparison of sensitivity and specificity of different detection methods. Vet. Microbiol., 83 (3): 235-248.
Usui, T.; Meas, S.; Konnai, S.; Ohashi, K. and Onuma, M. (2003): Seroprevalence of bovine immunodeficiency virus and bovine leukemia virus in dairy and beef cattle in Hokkaido. J. Vet. Med. Sci., 65 (2): 287-289.
VanLeeuwen, J.A.; Forsythe, L., Tiwari, A. and Chartier, R. (2005): Seroprevalence of antibodies against bovine leukemia virus, bovine viral diarrhea virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum in dairy cattle in Saskatchewan. Can. Vet. J., 46 (1): 56-58.
VanLeeuwen, J.A.; Tiwari, A.; Plaizier, J.C. and Whiting, T.L. (2006): Seroprevalences of antibodies against bovine leukemia virus, bovine viral diarrhea virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum in beef and dairy cattle in Manitoba. Can.Vet. J., 47 (8): 783-786.
Washburn, K.E.; Streeter, R.N.; Lehenbauer, T.W.; Snider, T.A.; Rezabek, G.B., Ritchey, J.W.; Meinkoth, J.H., Allison, R.W.; Rizzi, T.E.; and Boileau, M.J. (2007): Comparison of core needle biopsy and fine-needle aspiration of enlarged peripheral lymph nodes for antemortem diagnosis of enzootic bovine lymphosarcoma in cattle. J. Am.Vet. Med. Assoc., 230 (2): 228-232.
Willems, L.; Burny, A.; Collete, D.; Dangoisse, O.; Dequiedt, F.; Gatot, J.S.; Kerkhofs, P.; Lefèbvre, L.; Merezak, C.; Peremans, T.; Portetelle, D.; Twizere, J.C. and Kettmann, R. (2000): Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum.Retroviruses., 16 (16): 1787-1795.